1 Result for "

AZ14289671

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "AZ14289671" in MCE Product Catalog:

Cat. No.: HY-183682
CAS No.: 3101563-22-5
Target:  

EGFR p38 MAPK ERK Akt

Research Areas:  

Cancer

AZ14289671 is an orally active, blood-brain barrier-penetrant tyrosine kinase (tyrosine kinase) inhibitor (TKI) that specifically targets non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations (EGFR Exon20Ins), while largely sparing wild-type EGFR to reduce off-target toxicities such as rash and diarrhea. AZ14289671 inhibits the downstream MAPK/ERK/AKT pathway, suppressing tumor cell proliferation, survival and migration. AZ14289671 can be used for NSCLC research .
loading...
    loading...